Email this article European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience
- Authors: van der Ploeg A.T.1, Kruijshaar M.У.1, Toscano A.2, Laforet P.3, Angelini C.4, Lachmann R.H.5, Pascual Pascual S.I.6,7, Roberts M.8, Rosler K.9, Stulnig T.10, van Doorn P.A.11, Van den Bergh P.12, Vissing J.13, Schoser B.14
-
Affiliations:
- Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center
- Department of Clinical and Experimental Medicine, University of Messina
- Paris-Est, Referral Center for Neuromuscular Disorders, Pitie-Salpetriere Hospital, Assistance Publique Hopitaux de Paris
- Angelini Fondazione S. Camillo Hospital, IRCCS
- Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery
- Servicio de Neuropediatria, Hospital Universitario La Paz
- Department of Paediatrics, Universidad Autonoma de Madrid
- Department of Neurology, Salford Royal NHS Foundation Trust
- Salford
- Department of Medicine III, Medical University of Vienna
- Department of Neurology, Erasmus MC University Medical Center
- Department of Neurology, Neuromuscular Reference Centre, University Hospitals St-Luc
- Copenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen
- Friedrich-Baur-Institute, Ludwig-Maximilians-University
- Issue: Vol 8, No 4 (2018)
- Pages: 19-34
- Section: LECTURES AND REVIEWS
- Published: 11.01.2019
- URL: https://nmb.abvpress.ru/jour/article/view/301
- DOI: https://doi.org/10.17650/2222-8721-2018-8-4-19-34
- ID: 301
Cite item
Full Text
Abstract
About the authors
A. T. van der Ploeg
Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center
Author for correspondence.
Email: a.vanderploeg@erasmusmc.nl
Rotterdam Netherlands
M. Ую Kruijshaar
Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical CenterRotterdam Netherlands
A. Toscano
Department of Clinical and Experimental Medicine, University of MessinaMessina Italy
P. Laforet
Paris-Est, Referral Center for Neuromuscular Disorders, Pitie-Salpetriere Hospital, Assistance Publique Hopitaux de ParisParis France
C. Angelini
Angelini Fondazione S. Camillo Hospital, IRCCSVenice Italy
R. H. Lachmann
Charles Dent Metabolic Unit, National Hospital for Neurology and NeurosurgeryLondon United Kingdom
S. I. Pascual Pascual
Servicio de Neuropediatria, Hospital Universitario La Paz;Department of Paediatrics, Universidad Autonoma de Madrid
Madrid Spain
M. Roberts
Department of Neurology, Salford Royal NHS Foundation TrustSalford United Kingdom
K. Rosler
SalfordBern Switzerland
T. Stulnig
Department of Medicine III, Medical University of ViennaVienna Austria
P. A. van Doorn
Department of Neurology, Erasmus MC University Medical CenterRotterdam Netherlands
P.Y. K. Van den Bergh
Department of Neurology, Neuromuscular Reference Centre, University Hospitals St-LucBrussels Belgium
J. Vissing
Copenhagen Neuromuscular Center, Rigshospitalet, University of CopenhagenCopenhagen Denmark
B. Schoser
Friedrich-Baur-Institute, Ludwig-Maximilians-UniversityMunich Germany
References
Supplementary files
